Terminology Service for NFDI4Health
MART-1 Vaccinia Vaccine
Go to external page
http://purl.obolibrary.org/obo/NCIT_C2774
A cancer vaccine consisting of an attenuated recombinant vaccinia virus expressing the melanoma-associated antigen MART-1. Vaccination with this agent may stimulate cytotoxic host immune responses to melanoma cells. (NCI04) [ ]
Term info
Label
MART-1 Vaccinia Vaccine
Synonyms
- MART-1 Vaccinia Vaccine
- rV-MART1
Legacy Concept Name
MART-1_Vaccinia_Vaccine
NSC Code
674302
Preferred Name
MART-1 Vaccinia Vaccine
Semantic Type
Pharmacologic Substance, Immunologic Factor
UMLS CUI
C1518111
code
C2774
Term relations
Subclass of:
- Vaccinia Vaccine
- Chemical_Or_Drug_Has_Physiologic_Effect some T-Cell Activation
- Chemical_Or_Drug_Affects_Cell_Type_Or_Tissue some Cytotoxic T-Lymphocyte
- Chemical_Or_Drug_Has_Mechanism_Of_Action some Gene Regulation Process
- Chemical_Or_Drug_Affects_Abnormal_Cell some Melanoma Cell
- Chemical_Or_Drug_Has_Physiologic_Effect some Immunopotentiation